Inventor · disambiguated record
Shuntao Luo
Also filed as: LUO SHUNTAO
10 granted patents·1 pending application·4 citations·filing 2016–2022
79Inventor score
Files withGENOIMMUNE THERAPEUTICS CO LTD6BGI SHENZHEN4SICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD1
Top patents by PatentIndex Score
11 records- 0187US11466053B2Polypeptide and use thereofBGI SHENZHEN·Filed 2019·Granted Oct 11, 2022·4 cites·15 claims
- 0274US11820836B2Polypeptide and use thereofBGI SHENZHEN·Filed 2022·Granted Nov 21, 2023·0 cites·10 claims
- 0368US11390647B2Polypeptide and use thereofBGI SHENZHEN·Filed 2019·Granted Jul 19, 2022·0 cites·5 claims
- 0466US11834516B2Tumor-specific polypeptide and use thereofGENOIMMUNE THERAPEUTICS CO LTD·Filed 2021·Granted Dec 5, 2023·0 cites·6 claims
- 0562US11396528B2Polypeptide and use thereofBGI SHENZHEN·Filed 2019·Granted Jul 26, 2022·0 cites·14 claims
- 0660US11142547B2Polypeptide and use thereofGENOIMMUNE THERAPEUTICS CO LTD·Filed 2019·Granted Oct 12, 2021·0 cites·9 claims
- 0756US11213563B2Polypeptide and use thereofGENOIMMUNE THERAPEUTICS CO LTD·Filed 2019·Granted Jan 4, 2022·0 cites·15 claims
- 0853US11161874B2Tumor-specific polypeptide and use thereofGENOIMMUNE THERAPEUTICS CO LTD·Filed 2016·Granted Nov 2, 2021·0 cites·2 claims
- 0951US2022363781A1Anti-tslp antibody and uses thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 1050US11612643B2Col14A1-derived tumor antigen polypeptide and use thereofGENOIMMUNE THERAPEUTICS CO LTD·Filed 2016·Granted Mar 28, 2023·0 cites·8 claims
- 1142US11548925B2CACNA1H-derived tumor antigen polypeptide and use thereofGENOIMMUNE THERAPEUTICS CO LTD·Filed 2016·Granted Jan 10, 2023·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Shuntao Luo files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →